Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou

Henan Cancer Hospital, Zhengzhou

West China Hospital of Sichuan University, Chengdu

Affiliated Hospital of Hebei University, Baoding

Hunan Cancer Hospital, Changsha

Sichuan Cancer Hospital, Chengdu

Chongqing University Cancer Hospital, Chongqing

Fujian Cancer Hosppital, Fuzhou

Fujian Medical University Union Hospital, Fuzhou

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Guangdong Provincial People's Hospital, Guangzhou

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

Hainan General Hospital, Haikou

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

Harbin Medical University Cancer Hospital, Harbin

The Second Hospital of Anhui Medical University, Hefei

Affiliated Hospital of Jining Medical University, Jining

Lanzhou University Second Hospital, Lanzhou

The First Affiliated Hospital of Henan University of science and Technology, Luoyang

Meizhou People's Hospital, Meizhou

Jiangxi Cancer Hospital, Nanchang

Huashan Hospital, Fudan University, Shanghai

Liaoning Cancer Hospital & Institute, Shenyang

The First Hospital of China Medical University, Shenyang

The Forth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang

The Second Affiliated Hospital of Soochow University, Suzhou

Hubei Cancer Hospital, Wuhan

Tongji Hospital Tongji Medical College of HUST, Wuhan

The First Affiliated Hospital of Xiamen University, Xiamen

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou